Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diabetes

Free Subscription 13.10.2025 1 Am J Cardiol 1 Am J Ophthalmol 1 Angiology 3 BMC Ophthalmol 1 BMC Pediatr 5 Diabet Med 1 Diabetes 3 Diabetes Care 12 Diabetes Obes Metab 5 Diabetologia 2 J Am Soc Nephrol 3 J Clin Endocrinol Metab 2 J Diabetes Complications 1 J Nutr 1 JAMA 1 Kidney Int 1 Med J Aust 3 N Engl J Med 3 Pediatr Diabetes 11 PLoS One 1 Proc Natl Acad Sci U S A 1 Retina

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. HANSEN KN, Christiansen EH, Ellert-Gregersen J, Eftekhari A, et al
   Impact of Diabetes Mellitus on 5-year Outcomes after PCI with a Polymer-Free Drug-Coated Stent or a Biodegradable Polymer Ultra-thin Strut Stent.
   Am J Cardiol. 2025 Oct 2:S0002-9149(25)00601.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

2. WANG TW, Luo WT, Tu YK, Chou YB, et al
   Diagnostic Accuracy of EyeArt for Fundus-Based Detection of Diabetic Retinopathy: A Systematic Review and Meta-analysis.
   Am J Ophthalmol. 2025 Oct 4:S0002-9394(25)00528.
   PubMed         Abstract available
   
   

   
   Angiology

3. YUAN F, Liu M, Yan Y, Liu N, et al
   Reperfusion for Proximal Left Circumflex Artery Chronic Total Occlusion Benefits Patients With Diabetes: A Retrospective Cohort Study.
   Angiology. 2025 Oct 9:33197251377325. doi: 10.1177/00033197251377325.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

4. COSKUN C, Comcali S, Orman C
   Evaluation of corneal densitometry using Pentacam in patients with type 2 diabetes mellitus: a controlled cross-sectional study.
   BMC Ophthalmol. 2025;25:558.
   PubMed         Abstract available
   
   
5. WANG J, Shao Z, Li W, Zhao Y, et al
   Lipidomic analysis of vitreous humor derived from patients with proliferative diabetic retinopathy.
   BMC Ophthalmol. 2025;25:545.
   PubMed         Abstract available
   
   
6. LALWANI G, Wykoff CC, Briggs J, Lin CY, et al
   Progression of diabetic retinopathy in a longitudinal real-world study of patients in primary care.
   BMC Ophthalmol. 2025;25:547.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

7. ONGEN YD, Aydin AI, Atak M, Eren E, et al
   Performance of several large language models when answering common patient questions about type 1 diabetes in children: accuracy, comprehensibility and practicality.
   BMC Pediatr. 2025;25:799.
   PubMed         Abstract available
   
   

   
   Diabet Med

8. LITCHMAN ML, Berg CA, Porter M, Campbell MS, et al
   Family member involvement when multiple family members have type 1 diabetes.
   Diabet Med. 2025 Oct 6:e70145. doi: 10.1111/dme.70145.
   PubMed         Abstract available
   
   
9. KAUR A, Williams S, Bishop S
   Beyond compliance: Lived experiences of type 2 diabetes self-management in Wales.
   Diabet Med. 2025 Oct 6:e70152. doi: 10.1111/dme.70152.
   PubMed         Abstract available
   
   
10. PEMBERTON JS, Russon CL, Pulsford RM, Metcalf BS, et al
    Glucose-lowering effects of physical activity in type 1 diabetes: A causal modelling and matched-pair analysis approach.
    Diabet Med. 2025 Oct 8:e70146. doi: 10.1111/dme.70146.
    PubMed         Abstract available
    
    
11. HABTE-ASRES HH, Hailu F, Forbes A, Wheeler DC, et al
    Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta-analysis.
    Diabet Med. 2025 Oct 7:e70157. doi: 10.1111/dme.70157.
    PubMed         Abstract available
    
    
12. ZHU X, Chan FHF, Griva K
    Reframing the narrative in diabetes-related foot ulcer care: A primary care perspective.
    Diabet Med. 2025 Oct 7:e70143. doi: 10.1111/dme.70143.
    PubMed        
    
    

    
    Diabetes

13. KELLER F, Schunk S, Denicolo S, Sharifli S, et al
    Dickkopf-3 (DKK3) and the Progression of Diabetic Kidney Disease in Primary Health Care.
    Diabetes. 2025 Oct 10:db250235. doi: 10.2337/db25-0235.
    PubMed         Abstract available
    
    

    
    Diabetes Care

14. MARTINO M, Diakanthos M, Patrizi F, Cianfarani S, et al
    Successful Use of Omalizumab for Insulin Hypersensitivity in a Child with Type 1 Diabetes: 3 Years of Follow-up.
    Diabetes Care. 2025 Oct 9:dc251743. doi: 10.2337/dc25-1743.
    PubMed        
    
    
15. CAUSSY C, Cusi K, Rosenstock J, Bugianesi E, et al
    Relationship Between Metabolic and Histological Responses in People With Metabolic Dysfunction-Associated Steatohepatitis With and Without Type 2 Diabetes: Participant-Level Exploratory Analysis of the SYNERGY-NASH Trial With Tirzepatide.
    Diabetes Care. 2025 Oct 9:dc251306. doi: 10.2337/dc25-1306.
    PubMed         Abstract available
    
    
16. DUCHARME-SMITH A, Juntunen M, Espinoza A, Liedl C, et al
    Pilot Pragmatic Trial of a Community Paramedic Diabetes Self-Management Education Program for Adults With Diabetes.
    Diabetes Care. 2025 Oct 7:dc251580. doi: 10.2337/dc25-1580.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

17. MATHIESEN DS, Hansen JV, Hock A, Nielsen CK, et al
    Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial.
    Diabetes Obes Metab. 2025 Oct 6. doi: 10.1111/dom.70139.
    PubMed         Abstract available
    
    
18. AL OZAIRI E, Irshad M, Alkandari J, Sojan L, et al
    Weight loss in people with type 1 diabetes over 12 months: Real-world data comparing tirzepatide, semaglutide and liraglutide.
    Diabetes Obes Metab. 2025 Oct 6. doi: 10.1111/dom.70172.
    PubMed         Abstract available
    
    
19. SCARAMUZZA AE, Cherubini V
    The 'awareness effect': A crucial, un-modelleld economic benefit of national type 1 diabetes screening.
    Diabetes Obes Metab. 2025 Oct 6. doi: 10.1111/dom.70184.
    PubMed        
    
    
20. DI GIOIA L, Di Molfetta S, Caruso I, Caporusso M, et al
    Efficacy and safety of once-weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta-analysis.
    Diabetes Obes Metab. 2025 Oct 6. doi: 10.1111/dom.70176.
    PubMed         Abstract available
    
    
21. MONNIER L, Colette C, Benhamou PY, Owens D, et al
    Should glycaemic variability and times spent in levels 1 and 2 hypoglycaemia be revised downward in type 1 diabetes treated with advanced systems of insulin delivery?
    Diabetes Obes Metab. 2025 Oct 6. doi: 10.1111/dom.70179.
    PubMed        
    
    
22. ALGHAMDI M, Dihoum A, Hakami K, Bhattacharjee A, et al
    Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes.
    Diabetes Obes Metab. 2025 Oct 6. doi: 10.1111/dom.70164.
    PubMed         Abstract available
    
    
23. TUTTLE KR, Ji L, Mathieu C, Rosen J, et al
    Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review.
    Diabetes Obes Metab. 2025 Oct 6. doi: 10.1111/dom.70180.
    PubMed         Abstract available
    
    
24. POHLMANN J, Smith-Palmer J, Serne EH, Tuomaala AK, et al
    A systematic literature review and meta-analysis of real-world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes.
    Diabetes Obes Metab. 2025 Oct 8. doi: 10.1111/dom.70161.
    PubMed         Abstract available
    
    
25. ZHONG X, Zheng Y, Wang L, Ouyang B, et al
    Evaluating global epidemiology of type 2 diabetes mellitus among the working-age population: A 60-year study by interpretable machine learning framework.
    Diabetes Obes Metab. 2025 Oct 8. doi: 10.1111/dom.70155.
    PubMed         Abstract available
    
    
26. BANERJEE M, Pal R, Pal S
    Histological efficacy of anti-diabetic agents in MASH and the mediating role of weight loss: A network meta-analysis.
    Diabetes Obes Metab. 2025 Oct 8. doi: 10.1111/dom.70187.
    PubMed         Abstract available
    
    
27. PASQUA MR, Tsoukas MA, Haidar A
    Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post-hoc analysis from a double-blinded randomized controlled trial.
    Diabetes Obes Metab. 2025 Oct 8. doi: 10.1111/dom.70185.
    PubMed        
    
    
28. SKOP V, Lankova I, Antalova S, Miskova I, et al
    Partial non-adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross-sectional study using blood plasma analysis.
    Diabetes Obes Metab. 2025 Oct 10. doi: 10.1111/dom.70174.
    PubMed         Abstract available
    
    

    
    Diabetologia

29. FADINI GP
    No evidence that tirzepatide can worsen diabetic retinopathy.
    Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06564.
    PubMed        
    
    
30. BUCKLEY AJ, Tan GD, Gruszka-Goh M, Scanlon PH, et al
    No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter].
    Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06562.
    PubMed        
    
    
31. SLOAN G, Teh K, Greig M, Shillo P, et al
    Beyond pain relief: the effects of chronic opioid use on brain structure and function in diabetic neuropathy-a multimodal neuroimaging study.
    Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06529.
    PubMed         Abstract available
    
    
32. O'CONNELL MA, Beare R, Messazos B, Northam EA, et al
    Acute brain responses to hypoglycaemia and hyperglycaemia in adolescents with type 1 diabetes.
    Diabetologia. 2025 Oct 7. doi: 10.1007/s00125-025-06548.
    PubMed         Abstract available
    
    
33. MA C, Zeng H
    Methodological considerations for interpreting long-term statin use and diabetes incidence.
    Diabetologia. 2025 Oct 9. doi: 10.1007/s00125-025-06568.
    PubMed        
    
    

    
    J Am Soc Nephrol

34. WANG R, Xie J, Wang M
    Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD.
    J Am Soc Nephrol. 2025 Oct 10. doi: 10.1681/ASN.0000000867.
    PubMed        
    
    
35. SRIDHAR VS, Odutayo A, Davies MJ, Cherney DZI, et al
    Authors' Reply: Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD.
    J Am Soc Nephrol. 2025 Oct 10. doi: 10.1681/ASN.0000000868.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

36. CHEN NC, Shah VN, McQueen RB
    Time in Range and Incident Diabetic Retinopathy: Clinical and Economic Evidence from Real-World Type 1 Diabetes Care.
    J Clin Endocrinol Metab. 2025 Oct 4:dgaf544. doi: 10.1210.
    PubMed         Abstract available
    
    
37. LI Y, Zhang S, Lai Y, Wu P, et al
    Association of urinary copper and gestational diabetes mellitus: role of epigenome-wide DNA methylation and proteomics.
    J Clin Endocrinol Metab. 2025 Oct 6:dgaf555. doi: 10.1210.
    PubMed         Abstract available
    
    
38. KAGISAKI T, Baden MY, Oyama A, Noguchi M, et al
    Impact of Weight Change on Type 2 Diabetes Risk: A Prospective Study in a Japanese Population.
    J Clin Endocrinol Metab. 2025 Oct 8:dgaf558. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

39. SAMBATARO M, Sambado L, Colardo M, Furlan A, et al
    Neuroinflammation and osteomyelitis in adults with Type 2 diabetes mellitus and peripheral neuropathy without and with foot lesions. What comes first?
    J Diabetes Complications. 2025;39:109176.
    PubMed         Abstract available
    
    
40. CHRISTENSEN MMB, Hansen CS, Fleischer J, Senftleber N, et al
    The prevalence of diabetic neuropathy in Greenland and its association with Inuit genetic ancestry - a cross-sectional study.
    J Diabetes Complications. 2025;39:109179.
    PubMed         Abstract available
    
    

    
    J Nutr

41. GOKUL RAJ DK, Jayasuriya R, Ramkumar KM
    Hydroxytyrosol from Olive Oil Mitigates Endothelial Dysfunction in Diabetic Foot Ulcers via Redox, Inflammatory, and Survival Pathways.
    J Nutr. 2025 Oct 8:S0022-3166(25)00612-1. doi: 10.1016/j.tjnut.2025.
    PubMed         Abstract available
    
    

    
    JAMA

42. VAN DER WEL AWT, Frank CMC, Bout-Rebel R, Duijnhoven RG, et al
    Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial.
    JAMA. 2025 Sep 8:e2513668. doi: 10.1001/jama.2025.13668.
    PubMed         Abstract available
    
    

    
    Kidney Int

43. NAJAFIAN B, Caramori ML, Vestra MD, Saller A, et al
    Heterogeneity in the relationships between albuminuria and glomerular structure in type 1 and type 2 diabetes.
    Kidney Int. 2025 Oct 6:S0085-2538(25)00771-9. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    

    
    Med J Aust

44. THAPALIYA K, Sweeting A, Black KI, Poprzeczny A, et al
    Incidence of GLP-1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011-2022: a retrospective open cohort study.
    Med J Aust. 2025;223:365-371.
    PubMed         Abstract available
    
    

    
    N Engl J Med

45. KHAN H, Adnan F
    Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes.
    N Engl J Med. 2025;393:1442.
    PubMed        
    
    
46. SAMAJDAR SS, Joshi SR, Mukherjee S
    Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes.
    N Engl J Med. 2025;393:1442-1443.
    PubMed        
    
    
47. ROSENSTOCK J, Carr MC, Child CJ
    Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes. Reply.
    N Engl J Med. 2025;393:1443-1444.
    PubMed        
    
    

    
    Pediatr Diabetes

48. DEEB A, Eldeeb L, Suliman S, Chaturvedi D, et al
    Effect of an Intensive, Integrated Telehealth Intervention on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using Continuous Glucose Monitoring: A Randomized, Crossover Trial.
    Pediatr Diabetes. 2025;2025:7261998.
    PubMed         Abstract available
    
    
49. GOMEZ-MUNOZ L, Perna-Barrull D, Ventura PS, Valls A, et al
    Identification of Peripheral Blood Endotypes Associated With Age in Pediatric Type 1 Diabetes.
    Pediatr Diabetes. 2025;2025:5512196.
    PubMed         Abstract available
    
    
50. KRAUSOVA V, Neumann D, Stichova L, Skvor J, et al
    Alterations of Sublingual Microcirculation in Children With Compensated Type 1 Diabetes Mellitus-An Observational Study.
    Pediatr Diabetes. 2025;2025:8811411.
    PubMed         Abstract available
    
    

    
    PLoS One

51. TOFFALINI A, Vigolo N, Sani E, Paviati E, et al
    Hypervitaminosis A in type 2 diabetes and its relation with renal function and cardiovascular complications.
    PLoS One. 2025;20:e0333407.
    PubMed         Abstract available
    
    
52. BRENNER LN, Huang CY, Kim M, Bringhurst L, et al
    Dysglycemia and the airway microbiome in cystic fibrosis.
    PLoS One. 2025;20:e0331847.
    PubMed         Abstract available
    
    
53. LAEMANGO AM, Begna MB, Masebo DT, Anshebo DL, et al
    Diabetes mellitus and associated factors among psychiatric patients receiving antipsychotic treatment at Wachemo University Nigist Elleni Hospital, South Ethiopia.
    PLoS One. 2025;20:e0333284.
    PubMed         Abstract available
    
    
54. YADEGAR A, Mohammadi F, Heydarzadeh F, Mokhtarpour K, et al
    Can lipid indices aid in predicting diabetic kidney disease? Findings from a cross-sectional, matched case-control study.
    PLoS One. 2025;20:e0331756.
    PubMed         Abstract available
    
    
55. ZHAO K, Zhang G, Wu C, Wang D, et al
    Insights of red cell distribution width for mortality in septic patients with diabetes mellitus: A multicenter cohort study.
    PLoS One. 2025;20:e0333689.
    PubMed         Abstract available
    
    
56. YANG W, Cheng Q, Huang G, Lin H, et al
    Estimated glucose disposal rate predicts frailty through diabetes: Evidence from machine learning and mediation models in NHANES.
    PLoS One. 2025;20:e0333388.
    PubMed         Abstract available
    
    
57. LANGE FERREIRA C, Habte-Asres H, Forbes A, Winkley K, et al
    "It is a false safety net": A qualitative exploration of multiprofessional staff experiences of insulin management in hospitalised older or frail adults with diabetes undergoing surgery.
    PLoS One. 2025;20:e0332088.
    PubMed         Abstract available
    
    
58. TITUS AR, Kanchi R, Adhikari S, Thorpe LE, et al
    Time-varying associations between diabetes and mortality following COVID-19: Evidence from a U.S. Veteran population.
    PLoS One. 2025;20:e0333052.
    PubMed         Abstract available
    
    
59. BI Z, Wang F, Wang S, Fang Z, et al
    Immune repertoire profiling and T cell dysregulation in Peripheral Blood Mononuclear Cells of Type 2 diabetic patients.
    PLoS One. 2025;20:e0332736.
    PubMed         Abstract available
    
    
60. KODERA R, Tamura Y, Murao Y, Yorikawa F, et al
    Area of center of pressure in closed eye setting as a measure of postural sway: Association with frailty and functional capacity in older adults with diabetes.
    PLoS One. 2025;20:e0333608.
    PubMed         Abstract available
    
    
61. ZHANG J, Li W, Sun Z, Wang Y, et al
    Trends and projections of the global burden of T2DM-associated CKD related to high BMI: A global burden of disease study 2021.
    PLoS One. 2025;20:e0333672.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

62. SOTANI N, Kusuhara S, Nishisho R, Kuno H, et al
    Transpupillary in vivo two-photon imaging reveals enhanced surveillance of retinal microglia in diabetic mice.
    Proc Natl Acad Sci U S A. 2025;122:e2426241122.
    PubMed         Abstract available
    
    

    
    Retina

63. LU ES, Cui Y, Phu KK, Ding X, et al
    Expanded Field OCTA Biomarkers Associated with Future Cardiovascular Disease and Mortality in Patients with Diabetic Retinopathy.
    Retina. 2025 Sep 29. doi: 10.1097/IAE.0000000000004695.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.